Post-earnings recap
Reported
Fri, Jan 26, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
AbbVie's earnings report showed a positive surprise in EPS, which likely contributed to the stock's significant rise of 13.77%. The management's confident tone and focus on strong performance in key areas suggest that the company is on a solid path moving forward. However, the lack of revenue data and guidance may leave some investors cautious.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.48 | N/A | +2.08% |
| Revenue | N/A | N/A | N/A |
Management expressed confidence in the company's ongoing performance. They highlighted strong results in their core products and a commitment to future growth.
The company continues to show strong performance in key therapeutic areas.
We are committed to delivering value to our shareholders.